GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Institutional Ownership

RLFTF (Relief Therapeutics Holding) Institutional Ownership : 0.00% (As of Dec. 13, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Relief Therapeutics Holding Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Relief Therapeutics Holding's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Relief Therapeutics Holding's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Relief Therapeutics Holding's Float Percentage Of Total Shares Outstanding is 70.79%.


Relief Therapeutics Holding Institutional Ownership Historical Data

The historical data trend for Relief Therapeutics Holding's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Institutional Ownership Chart

Relief Therapeutics Holding Historical Data

The historical data trend for Relief Therapeutics Holding can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 1.75 1.71 1.78 1.78 1.76 1.76 1.76 2.00 2.55 2.55

Relief Therapeutics Holding Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Relief Therapeutics Holding Business Description

Traded in Other Exchanges
Address
Avenue de Secheron 15, Geneva, CHE, 1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.